Top

Current Pulmonology Reports

Published in:

01-03-2017 | Nutrition in Clinical Care (J Patel, Section Editor)

Interstitial Lung Disease, Body Mass Index, Energy Expenditure and Malnutrition—a Review

Authors: Sylvia Rinaldi, Marco Mura, Janet Madill

Published in: Current Pulmonology Reports | Issue 1/2017

Abstract

Purpose of Review

Interstitial lung disease (ILD) comprises a spectrum of chronic disorders that cause various degrees of inflammation or fibrosis in the pulmonary interstitium. Although limited, data exists on nutritional concerns in ILD. However, previous research has not fully explored the broad range of potential nutritional concerns in ILD and impacts on outcomes. The purpose of this review was to identify and describe the overall nutritional status and relating concerns within the ILD population.

Recent Findings

Appropriate weight management in this population may positively impact both pre- and post-transplant survival. Additionally, accounting for adequate muscle mass may predict better outcomes than considering body mass index alone. Current research has identified risk of malnutrition related to decreased muscle strength, increased energy expenditure, vitamin D deficiency, and increased risk of osteoporosis and osteopenia.

Summary

Current research is preliminary and further research is necessary to identify established nutritional complications in this population.

Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63 Suppl 5:v1–58.PubMed

Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.PubMedPubMedCentral

Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48.CrossRefPubMedPubMedCentral

Mura M, Porretta MA, Bargagli E, Sergiacomi G, Zompatori M, Sverzellati N, et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur Respir J. 2012;40(1):101–9.PubMed

Collard H, King T, Bartelson B, Vourlekis J, Schwarz M. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168(5):538–42.PubMed

Richeldi L, Davies HHRHR, Spagnolo P, Luppi F. Corticosteroids for idiopathic pulmonary fibrosis. The Cochrane Collaboration, Richeldi L, editors. Database Syst Rev. 2003;(3):1–13.

Spagnolo P, Del Giovane C, Luppi F, Cerri S, Balduzzi S, Walters EH, et al. Non-steroid agents for idiopathic pulmonary fibrosis. The Cochrane Collaboration, editor. Cochrane Database Syst Rev. 2010;(9):1–74.

Hunninghake GM. A new hope for idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2142–3.PubMed

Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–82.PubMed

10.

Crockett AJ, Cranston JM, Antic N. Domiciliary oxygen for interstitial lung disease. The Cochrane Collaboration, Crockett A, editors. Cochrane Database Syst Rev. 2001;(3):CD002883.

11.

Holland AE, Hill C. Physical training for interstitial lung disease. The Cochrane Collaboration, Holland AE, editors. Cochrane Database Syst Rev. 2008;(4).

12.

Yusen RD, Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, et al. The registry of the international society for heart and lung transplantation: thirtieth adult lung and heart-lung transplant report—2013; focus theme: age. J Heart Lung Transplant. 2013;32(10):965–78.PubMed

13.

CIHI. Canadian organ replacement register annual report: Treatment of end-stage organ failure in Canada, 2004 to 2013 [Internet]. 2014 [cited 2016 Mar 18]. p. 1–129. Available from: https://secure.cihi.ca/free_products/2015_CORR_AnnualReport_ENweb.pdf.

14.

Madill J, Maurer JR, de Hoyos A. A comparison of preoperative and postoperative nutritional states of lung transplant recipients. Transplantation. 1993;56(2):347–50.PubMed

15.

Madill J, Gutierrez C, Grossman J, Allard J, Chan C, Hutcheon M, et al. Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation. J Heart Lung Transplant. 2001;20(3):288–96.PubMed

16.

Culver DA, Mazzone PJ, Khandwala F, Blazey HC, Decamp MM, Chapman JT. Discordant utility of ideal body weight and body mass index as predictors of mortality in lung transplant recipients. J Heart Lung Transplant. 2005;24(2):137–44.PubMed

17.

Gries CJ, Bhadriraju S, Edelman JD, Goss CH, Raghu G, Mulligan MS. Obese patients with idiopathic pulmonary fibrosis have a higher 90-day mortality risk with bilateral lung transplantation. J Heart Lung Transplant. 2015;34(2):241–6.PubMed

18.

• Singer JP, Peterson ER, Snyder ME, Katz PP, Golden JA, D’Ovidio F, et al. Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med. 2014;190(9):1012–21. This study provides novel insight into the relationship between body composition and outcomes. Previous research mainly focuses on BMI, however, authors have shown that results based on BMI alone do not yield the same results when one accounts for skeletal muscle mass.PubMedPubMedCentral

19.

Tynan C, Hasse JM. Current nutrition practices in adult lung transplantation. Nutr Clin Pract. 2004;19(6):587–96.PubMed

20.

Alakhras M, Decker PA, Nadrous HF, Collazo-Clavell M, Ryu JH. Body mass index and mortality in patients with idiopathic pulmonary fibrosis. Chest. 2007;131(5):1448–53.PubMed

21.

Celli B, Cote C, Marin J, Casanova C, Montes de Oca M, Mendez R, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–12.PubMed

22.

Cano N, Raphael J-C, Roth CM, Pichard C, Roth H, Isabelle C, et al. C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest. 2004;126(2):540–6.PubMed

23.

Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–61.PubMed

24.

Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1791–7.PubMed

25.

Chailleux E, Fauriux B, Binet F. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation: a 10-year analysis of ANTADIR Observatory. Chest. 1996;109(2):741–9.PubMed

26.

Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis. 1989;139(6):1435–8.PubMed

27.

Gonzalez M, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr. 2014;99(5):999–1005.PubMed

28.

• Mendes PO, Wickerson L, Helm DE, Janaudis-ferreira TA, Brooks D, Singer LIG, et al. Skeletal muscle atrophy in advanced interstitial lung disease. 2015;20(6):953–9. This study focuses on physical activity in ILD and provides novel data on physical functionality. Implications from this research is directly related to nutrition as exercise training and rehabiliation may be enhanced by adequate nutrition intake.

29.

Cawood AL, Elia M, Stratton R. Systematic review and meta-analysis of the effects of high protein oral nutritional supplements. Ageing Res Rev. 2012;11(2):278–96.PubMed

30.

Slinde F, Grönberg AM, Svantesson U, Hulthén L, Larsson S. Energy expenditure in chronic obstructive pulmonary disease-evaluation of simple measures. Eur J Clin Nutr. 2011;65(12):1309–13.PubMed

31.

Nordenson A, Gronberg AM, Hulthen L, Larsson S, Slinde F. A validated disease specific prediction equation for resting metabolic rate in underweight patients with COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:271–6.PubMedPubMedCentral

32.

Slinde F, Grönberg A, Svantesson U, Hulthén L, Larsson S. Energy expenditure in chronic obstructive pulmonary disease—evaluation of simple measures. Eur J Clin Nutr. 2011;65(12):1309–13.PubMed

33.

Ryerson CJ, Collard HR, Pantilat SZ. Management of dyspnea in interstitial lung disease. Curr Opin Support Palliat Care. 2010;4(2):69–75.PubMed

34.

Fitting J, Frascarolo P, Jequier E, Leuenberger P. Energy expenditure in interstitial lung disease. Am Rev Respir Dis. 1990;142(3):631–5.PubMed

35.

Norman K, Pichard C, Lochs H, Pirlich M. Prognostic impact of disease-related malnutrition. Clin Nutr. 2008;27(1):5–15.PubMed

36.

Detsky A, McLaughlin JR, Baker J. What is subjective global assessment of nutritional status? JPEN. 1987;11(1):8–13.

37.

Günay E, Kaymaz D, Selçuk NT, Ergün P, Sengül F, Demir N. Effect of nutritional status in individuals with chronic obstructive pulmonary disease undergoing pulmonary rehabilitation. Respirology. 2013;18:1217–22.PubMed

38.

Gupta B, Kant S, Mishra R. Subjective global assessment of nutritional status of chronic obstructive pulmonary disease patients on admission. Int J Tuberc Lung Dis. 2010;14(4):500–5.PubMed

39.

Autore K, Black T, Klesen M, Richards T, Gibson K, Kaminski N, et al. Evaluating nutritional status of patients with idiopathic pulmonary fibrosis: a prospective pilot study using the mini nutrition assessment short from. In: A42 Interstitial Lung Disease: Epidemiology, Evaluation and Pathogenesis. Philadelphia Pennsylvania: American Thoracic Society; 2013. p. A1461–A1461.

40.

Buhr G, Bales CW. Nutritional supplements for older adults: review and recommendations--Part II. J Nutr Elder. 2010;29(1):42–71.PubMed

41.

Buhr G, Bales CW. Nutritional supplements for older adults: review and recommendations—part I. J Nutr Elder. 2009;28(1):5–29.PubMed

42.

McCaddon A. Vitamin B12 in neurology and ageing; clinical and genetic aspects. Biochimie. 2013;95(5):1066–76.PubMed

43.

Arai T, Inoue Y, Sasaki Y, Tachibana K, Nakao K, Sugimoto C, et al. Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis. Respir Investig. 2014;52:136–43.PubMed

44.

de Groot L. Nutritional issues for older adults: addressing degenerative ageing with long-term studies. Proc Nutr Soc. 2016;75(2):169–73.PubMed

45.

Lems WF, Van Veen GJ, Gerrits MI, Jacobs JW, Houben HH, Van Rijn HJ, et al. Effect of low-dose prednisone (with calcium and calcitriol supplementation) on calcium and bone metabolism in healthy volunteers. Br J Rheumatol. 1998;37(1):27–33.PubMed

46.

Finklea JD, Grossmann RE, Tangpricha V. Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies. Adv Nutr. 2011;2(3):244–53.PubMedPubMedCentral

47.

Hagaman J, Panos R, McCormack F, Thakar C, Wikenheiser-Brokamp K, Shipley R, et al. Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases. 2011;139(2):353–60.

48.

Mascitelli L, Pezzetta F, Goldstein MR, Waschki B, Kirsten A. Vitamin D and mortality from pulmonary fibrosis a positive end-expiratory pressure effect. Chest. 2010;137(2):495–6.PubMed

49.

Olson A, Swigris J, Raghu G, Brown KK. Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter. Chest. 2009;136(1):16–22.PubMed

50.

Ramirez A, Wongtrakool C, Welch T, Steinmeyer A, Zugel U, Roman J. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol. 2010;118(3):142–50.PubMed

51.

•• Alhamad EH, Nadama R. Bone mineral density in patients with interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis. 2015;32:151–9. This study identified osteoporosis and ostepenia and a clinically signicant portion of their sample. Authors found that increasing age, UIP diagnosis, higher partial pressure of carbon dioxide, hypertension and diabetes.PubMed

Title: Interstitial Lung Disease, Body Mass Index, Energy Expenditure and Malnutrition—a Review
Authors: Sylvia Rinaldi
Marco Mura
Janet Madill
Publication date: 01-03-2017
Publisher: Springer US
Published in: Current Pulmonology Reports / Issue 1/2017
Electronic ISSN: 2199-2428
DOI: https://doi.org/10.1007/s13665-017-0168-x

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Interstitial Lung Disease, Body Mass Index, Energy Expenditure and Malnutrition—a Review

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 1/2017

Chest Drain Size: the Debate Continues

Blood Patch for Pneumothorax: a Literature Review

Identifying nutritional risk in critical illness

The obesity paradox: validity and clinical implications

Optimizing Enteral Nutrition in Medical Intensive Care Patients

Persistent, Immunosuppression, Inflammation, Catabolism Syndrome and Diaphragmatic Dysfunction

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page